National Health Investors, Inc. (NYSE:NHI) Sees Large Decrease in Short Interest

National Health Investors, Inc. (NYSE:NHI) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 1,387,280 shares, a drop of 29.8% from the December 15th total of 1,975,807 shares. Approximately 3.2% of the company’s stock are short sold. Based on an average daily volume of 230,633 shares, the short-interest ratio is presently 6.0 days. Based on an average daily volume of 230,633 shares, the short-interest ratio is presently 6.0 days. Approximately 3.2% of the company’s stock are short sold.

Institutional Trading of National Health Investors

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of National Health Investors by 0.8% in the third quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock worth $516,624,000 after acquiring an additional 52,474 shares in the last quarter. State Street Corp raised its stake in National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after purchasing an additional 95,812 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of National Health Investors by 34.0% in the third quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of National Health Investors by 4.5% in the second quarter. Geode Capital Management LLC now owns 1,232,524 shares of the real estate investment trust’s stock worth $86,434,000 after buying an additional 53,630 shares during the period. Finally, Centersquare Investment Management LLC grew its holdings in shares of National Health Investors by 21.8% during the third quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock valued at $78,443,000 after buying an additional 176,410 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on NHI shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. Cantor Fitzgerald set a $85.00 price objective on National Health Investors in a research note on Monday, January 5th. Truist Financial boosted their target price on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research note on Monday, December 15th. KeyCorp increased their target price on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Finally, Wells Fargo & Company lifted their price target on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $86.50.

National Health Investors Price Performance

NYSE:NHI traded down $0.34 during midday trading on Friday, hitting $80.09. 260,061 shares of the stock were exchanged, compared to its average volume of 175,435. The business has a 50-day moving average price of $77.80 and a two-hundred day moving average price of $76.00. National Health Investors has a one year low of $65.22 and a one year high of $80.87. The company has a market capitalization of $3.82 billion, a price-to-earnings ratio of 25.26, a P/E/G ratio of 2.99 and a beta of 0.67. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74.

National Health Investors (NYSE:NHI) last issued its earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. The firm had revenue of $83.36 million during the quarter, compared to analysts’ expectations of $85.66 million. During the same period last year, the firm posted $1.03 earnings per share. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. Sell-side analysts predict that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio is currently 116.09%.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.